三星医疗：董监高减持股份结果公告

Core Points - Samsung Medical announced the completion of a stock reduction plan by its director and board secretary, Ms. Guo Su, who has reduced her holdings by 150,000 shares, representing approximately 0.01% of the company's total share capital [2] Summary by Category - Company Actions - Ms. Guo Su has executed a stock reduction through centralized bidding, completing the planned reduction of 150,000 shares [2] - Shareholder Impact - The reduction of shares by Ms. Guo Su is a minor adjustment, affecting only 0.01% of the total share capital, indicating limited immediate impact on the overall shareholder structure [2] - Market Reaction - The announcement of the stock reduction plan's completion may influence market perceptions of the company's governance and insider trading activities, although the scale of the reduction is relatively small [2]